Cargando…

Abplatin((IV)) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin

BACKGROUND: Cisplatin, the alkylating agent of platinum(II) (Pt(II)), is the most common antitumor drug in clinic; however, it has many side effects, therefore it is higly desired to develop low toxicity platinum(IV) (Pt(IV)) drugs. Multi-omics analysis, as a powerful tool, has been frequently emplo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xing, Zhang, Lingpu, Li, Tuo, Li, Shumu, Wu, Wenjing, Zhao, Lingyu, Xie, Peng, Yang, Jinqi, Li, Peipei, Zhang, Yangyang, Xiao, Haihua, Yu, Yingjie, Zhao, Zhenwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164404/ https://www.ncbi.nlm.nih.gov/pubmed/35659243 http://dx.doi.org/10.1186/s12951-022-01465-y

Ejemplares similares

Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models
por: Shang, Kun, et al.
Publicado: (2023)

Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair–inhibiting (HYDRI) nanomedicine
por: Chen, Jing, et al.
Publicado: (2021)

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
por: Li, Zhao, et al.
Publicado: (2017)

Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
por: Zhou, Huiling, et al.
Publicado: (2023)

Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance
por: Wang, Yongheng, et al.
Publicado: (2021)

Liposomes embedded with PEGylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer
por: Liu, Yang, et al.
Publicado: (2022)

Oxeiptosis core genes and their multi-omics analysis in hepatocellular carcinoma
por: Lin, Sen, et al.
Publicado: (2023)

Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
por: Xiao, Xiao, et al.
Publicado: (2019)

Regulating the surface topography of CpG nanoadjuvants via coordination-driven self-assembly for enhanced tumor immunotherapy
por: Zhang, Li, et al.
Publicado: (2023)

Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor
por: Liu, Xingkai, et al.
Publicado: (2022)

Composition and sequence-controlled conductance of crystalline unimolecular monolayers
por: Wang, Jinxin, et al.
Publicado: (2023)

Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method
por: He, Bing, et al.
Publicado: (2017)

Community-integrated multi-omics facilitates screening and isolation of the organohalide dehalogenation microorganism
por: Huang, Yiqun, et al.
Publicado: (2022)

Mitochondrial fission factor promotes cisplatin resistancein hepatocellular carcinoma: Mff promotes cisplatin resistance in HCC
por: Li, Xiaoliang, et al.
Publicado: (2022)

Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2021)

Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma
por: Qiao, Gan, et al.
Publicado: (2018)

Theoretical analysis of the thermoelectric properties of penta-PdX2 (X = Se, Te) monolayer
por: Li, Lei, et al.
Publicado: (2022)

Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
por: Sui, Qihai, et al.
Publicado: (2022)

Multi-Omic Analyses of the m(5)C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin
por: Cai, Shijiao, et al.
Publicado: (2020)

Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
por: Zhang, Ruixue, et al.
Publicado: (2019)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3
por: Xie, Tao, et al.
Publicado: (2016)

Deep learning‐based multi‐omics study reveals the polymolecular phenotypic of diabetic kidney disease
por: Zhao, Huan, et al.
Publicado: (2023)

Editorial: Omics data-based identification of plant specialized metabolic genes
por: Wang, Peipei, et al.
Publicado: (2023)

Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
por: Cui, Dawei, et al.
Publicado: (2021)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2019)

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
por: Xiang, Dongquan, et al.
Publicado: (2023)

Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV
por: Xing, Peipei, et al.
Publicado: (2016)

Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles
por: Lu, Xiaona, et al.
Publicado: (2023)

Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes
por: Yang, Xiao, et al.
Publicado: (2022)

Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma
por: Chen, Juan, et al.
Publicado: (2017)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Multi-omic analysis reveals HIP-55-dependent regulation of cytokines release
por: Jiang, Yunqi, et al.
Publicado: (2020)

Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III–IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus
por: Zhao, Qian, et al.
Publicado: (2019)

Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma
por: Zhang, Qiangnu, et al.
Publicado: (2021)

Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
por: Liu, Xiao-Na, et al.
Publicado: (2019)

Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer
por: Shao, Qian, et al.
Publicado: (2017)

Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature
por: Li, Qiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vmisrurr67q6tjee2hoomem3vl